Plain-English translation of NCT07048574 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at how depression, anxiety, and behavior problems show up in young children with cystic fibrosis. Researchers want to understand how common these mental health concerns are, which screening tools work best for young children, and whether newer CF medications might be linked to any mood or behavior changes.
Until now, mental health screening in cystic fibrosis has focused mainly on teenagers and adults—young children under 12 have been left out of this important work. At the same time, anxiety and depression in young children have become more common, and new cystic fibrosis treatments have been introduced that doctors want to monitor carefully for any emotional or behavioral side effects.
You likely qualify if…
You likely don't qualify if…
You and your child will be asked to complete questionnaires about mood, anxiety, and behavior at your CF center visits. Depending on your child's age, they may answer some questions themselves (children 8 and older) or you may answer on their behalf. The study follows children over time, so you'll complete these same screening tools at multiple visits to track how things change. If your child is taking a newer CF medication, researchers may also ask you about any mood or behavior changes you've noticed.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States